Circulatory 25(OH)D and 1,25(OH)2D as differential biomarkers between multiple system atrophy and Parkinson's disease patients
Background and purpose: There is sufficient evidence to support vitamin D's noncalcemic effects and the role of vitamin D deficiency in the development of a wide range of neurological disorders. This study aimed to evaluate whether serum 25(OH)D and 1,25(OH) 2 D could be used as biomarkers to d...
Main Authors: | Hiromu Ogura, Izzettin Hatip-Al-Khatib, Midori Suenaga, Funda Bolukbasi Hatip, Takayasu Mishima, Shinsuke Fujioka, Shinji Ouma, Yoichi Matsunaga, Yoshio Tsuboi |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | eNeurologicalSci |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405650221000617 |
Similar Items
-
Time-Specific Pattern of Iron Deposition in Different Regions in Parkinson's Disease Measured by Quantitative Susceptibility Mapping
by: Xiaodi Fu, et al.
Published: (2021-08-01) -
Plasma and Serum Alpha-Synuclein as a Biomarker of Diagnosis in Patients With Parkinson's Disease
by: Chun-Wei Chang, et al.
Published: (2020-01-01) -
Functional gait assessment in early and advanced Parkinson’s disease
by: Hany Mohamed Eldeeb, et al.
Published: (2021-10-01) -
Correlation between 25-hydroxy-vitamin D and Parkinson's disease
by: Ming Xia, et al.
Published: (2024-06-01) -
Apathy-Related Symptoms Appear Early in Parkinson’s Disease
by: Emmie Cohen, et al.
Published: (2022-01-01)